Patent classifications
C07K1/02
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
The present invention relates to methods and formulations useful for reducing the reconstitution time of lyophilized polypeptides.
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
The present invention relates to methods and formulations useful for reducing the reconstitution time of lyophilized polypeptides.
Compounds for use in synthesis of peptidomimetics
Synthesis of O-benzotriazole and O-imidazole synthons are described. Uses of synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the synthons and uses of azapeptides and other peptidomimetics are also described.
HUMAN PLACENTAL COLLAGEN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.
HUMAN PLACENTAL COLLAGEN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.
Method for producing high-concentration collagen for using as medical material
Disclosed is a method of producing high-concentration collagen for use as a medical material, including: washing tissue of a mammal; subjecting the washed tissue to crushing and immersion in ethyl alcohol; subjecting the tissue to enzymatic treatment with stirring in purified water containing phosphoric acid and pepsin; adding sodium chloride to the collagen subjected to enzymatic treatment, performing stirring, and aggregating collagen; dissolving the aggregated collagen in purified water to give a collagen solution, which is then filtered using a filter and concentrated by removing the pepsin, low-molecular-weight material, and sodium chloride from the collagen solution using a tangential flow filtration device; subjecting the concentrated collagen to sterile filtration, aggregating the collagen using a pH solution in a neutralization tank, and concentrating the collagen by removing a non-aggregated solution; and concentrating the concentrated collagen using a centrifuge and stirring the concentrated collagen using a mixer.
METHOD FOR MANUFACTURING PROTEOGLYCAN-CONTAINING COMPOSITION, AND PROTEOGLYCAN-CONTAINING COMPOSITION
A method for manufacturing a proteoglycan-containing composition including: a freezing step for freezing a starting material, where raw cartilage derived from fish is used as the starting material; and a freeze-drying step for freeze-drying frozen articles obtained in the freezing step. The method may also include an extraction step for furthermore adding an aqueous solvent to the resultant freeze-dried articles to carry out extraction. Additionally, a method for manufacturing a proteoglycan-containing composition including a mincing step for forming a starting material into surimi, where raw cartilage derived from fish is used as the starting material; and an extraction step for adding an aqueous solvent to the surimi obtained in the mincing step to carry out extraction.
METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND
Provided are a method for producing a peptide compound including a step of using a condensed polycyclic aromatic hydrocarbon compound represented by Formula (1); a protective group-forming reagent including the compound; and the compound. In Formula (1), a ring A represents a condensed polycyclic aromatic hydrocarbon ring, Y.sup.A's each independently represent —OH, —NHR, —SH, or —X.sup.0, where X.sup.0 represents Cl, Br, or I, R.sup.A and R.sup.C each independently represent an aliphatic hydrocarbon group or an organic group having an aliphatic hydrocarbon group, R.sup.Bs' each independently represent a monovalent aliphatic hydrocarbon group, a (1+c)-valent aromatic group, or a (1+c)-valent heteroaromatic group, where, in a case where both a and c is 0, R.sup.B is a monovalent aliphatic hydrocarbon group, and the number of carbon atoms in at least one aliphatic hydrocarbon group is 12 or more.
##STR00001##
SYNTHESIS STRATEGY FOR GAP PROTECTING GROUP
The present invention relates to a novel synthesis method to form particular molecules. These molecules have multiple uses, most notably in the field of protecting groups used throughout organic and synthetic chemistry. The disclosed method is safer, more cost- and time-effective, and more amenable to large scale production than those currently known in the art. The protecting groups synthesized are useful in GAP peptide synthesis.
SYNTHESIS STRATEGY FOR GAP PROTECTING GROUP
The present invention relates to a novel synthesis method to form particular molecules. These molecules have multiple uses, most notably in the field of protecting groups used throughout organic and synthetic chemistry. The disclosed method is safer, more cost- and time-effective, and more amenable to large scale production than those currently known in the art. The protecting groups synthesized are useful in GAP peptide synthesis.